spacer
home > events calendar
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR
   
  {prev}
EVENTS FOR 2018
{next}  
   
 
EVENTS FOR ALL MAGAZINES
 
     

Pharma and Device Packaging and Labelling West Coast 2018

27-28 November 2018
Burlingame, CA

The second edition of the Pharma and Device Packaging and Labeling West Coast was a thought-provoking two days of engaging presentations, discussion and networking. More>>

 
 

Partnerships in Clinical Trials Europe 2018

27-29 November 2018
CCIB, Barcelona

Partnerships in Clinical Trials Europe is back – and bigger than ever. Europe’s most complete clinical meeting is bringing together 1000+ of the industry’s leading experts this November for it’s 17th annual gathering, and you’re invited! More>>

 
phone +44 (0)20 3377 3279
email LS.Registrations@Knect365.com
web lifesciences.knect365.com/pct-europe/
email CCIB, Barcelona
 

RDD Asia 2018

14-15 November 2018
Grand Hyatt Kochi, Kerala, India

A must-attend meeting for pulmonary and nasal researchers, inhaled product developers and vendors active in this important pharmaceutical niche. More>>

 
phone tel:+01-804-827-1490
email rddasia@rddonline.com
web www.rddonline.com/rddasia2018
email RDD Asia 2018, Grand Hyatt Kochi, Kerala, India
 

10th Annual NGS & Clinical Diagnostics Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its 10thAnnual NGS & Clinical Diagnostics Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2jYBa44
email London
 

6th Annual Single Cell Analysis Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its 6th Annual Single Cell Analysis Congress taking place on 8-9 November 2018 in London.  Part of the Genomics & Synthetic Biology Series UK, the congress will bring together over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2wJJRsc
email London
 

Synthetic Biology Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its Synthetic Biology Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2MtRRQY
email London
 

4th Annual Genome Editing Congress

8-9 November 2018
London, UK

Oxford Global is proud to present its 4thAnnual Genome Editing Congress taking place on 8-9 November 2018 in London. As part of our Genomics and Synthetic Biology UK series, our congress will bring together Over 600 delegates representing internationally renowned research & academic institutions, clinical research institutions and pharmaceutical companies. More>>

 
phone +44 (0)1865 248455
email d.dalby@oxfordglobal.co.uk
web https://bit.ly/2tHrM9q
email London
 

BIO-Europe 2018-24th Annual International Partnering Conference

5-7 November 2018
Bella Center Copenhagen, Denmark

The 24th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe. Over 4,000 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward. More>>

 
 

SAPHEX 2018

1-2 November 2018
Gallagher Convention Centre, Midrand, South Africa

The SAPHEX exhibition and conference is now established as the “go-to” networking and business event for anyone working in the South African pharmaceutical manufacturing industry. More>>

 
phone 0044 (0) 203 198 9622
email jessica@saphex.co.za
web www.saphex.co.za
email Gallagher Convention Centre, Midrand, South Africa
 
spacer
Industry Events

Clinical Trials Europe | Partnerships, Outsourcing, Operations & Technology

27 August - 21 November 2019, Barcelona, Spain

On 19-21 November 2019, the clinical trial community's most influential stakeholders will be meeting in Barcelona to discuss the evolving landscape, honing in on what it takes to harness true value from partnerships, outsourcing, operations, technology and early clinical development, for a faster, more efficient route to market.
More info >>

White Papers

Orthogonal Approaches for the Analysis of Protein Sequence and Post Translational Modifications of a Monoclonal Antibody

RSSL

Monoclonal antibodies are an important class of biopharmaceuticals. They are expressed from living cells and therefore, are subject to complex biochemical pathways. Not all of these pathways are fully understood and many are known to be sensitive to subtle environmental changes during production. These changes may affect the final biopharmaceutical sequence, structure and post-translational modifications. This is in addition to any changes that may occur during subsequent purification. This means that the final product from one batch may be subtly different from another batch. Furthermore, each batch is a heterogeneous mix of similar molecules. Analysis of the degree of batch-tobatch variation, and batch heterogeneity, is therefore, very important to establish in order to be confident that the drug is safe and effective for medicinal use.
More info >>


News and Press Releases

Drivers behind Saudi Arabia’s forecast 10.74 $billion 2022 market explored ahead of CPhI MEA

Saudi Arabia’s pharmaceutical market expected to grow at a CAGR of 5.5% until 2023. Growing population, increase in non-communicable diseases and major investment in new hospitals, clinics and treatments driving growth
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement